Pharmacological inhibition of RAGE signaling through specific antagonists TTP488 or FPSZM1 reduces neuroinflammation and amyloid deposition and improves behavioral performance in AD mouse models [49,50]. This evidence concerns the gene AGER and Alzheimer disease.